HALO

Halozyme Therapeutics, Inc. is an innovative biopharmaceutical company headquartered in San Diego, California, recognized for its groundbreaking drug delivery technologies that significantly enhance the effectiveness of existing therapies. Utilizing its proprietary ENHANZE® technology, Halozyme focuses on developing subcutaneous formulations that improve patient adherence and outcomes across a range of indications. The company strategically collaborates with industry-leading pharmaceutical partners, thereby expanding its therapeutic offerings and solidifying its role as a key player in the biotechnology sector. With a global operational footprint in the U.S., Europe, and Asia, Halozyme is well-positioned to meet the growing demand for more effective and patient-friendly therapeutic solutions.